ClinicalTrials.gov
ClinicalTrials.gov Menu

Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01420172
Recruitment Status : Completed
First Posted : August 19, 2011
Last Update Posted : February 27, 2017
Sponsor:
Information provided by (Responsible Party):
Karen Wood, Ohio State University

Brief Summary:

This will be a retrospective study and analysis of subjects who have undergone a hematopoietic stem transplant (either at OSUMC or external location) and were seen at OSUMC at any time between 01Jan2000 and 30Jun2011.

This study will determine factors influencing pulmonary disease and associated treatment strategies.


Condition or disease Intervention/treatment
Post Hematopoietic Stem Cell Transplantation Other: Data Collection

Study Type : Observational
Actual Enrollment : 200 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation.
Study Start Date : August 2011
Actual Primary Completion Date : July 8, 2016
Actual Study Completion Date : July 8, 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Lung Diseases

Group/Cohort Intervention/treatment
Post hematopoietic stem cell transplantation
Patients who were seen post hematopoietic stem cell transplantation between 01Jan2000 and 30Jun2011
Other: Data Collection
Collection of data on patients who were seen at OSUMC at any time between 01Jan2000 and 30Jun2011 post hematopoietic stem cell transplantation




Primary Outcome Measures :
  1. A retrospective diagnostic review on pulmonary disease related to hematopoietic stem cell transplantation. [ Time Frame: Up to 15 years ]
    To determine factors influencing pulmonary disease related to HSCT.


Secondary Outcome Measures :
  1. A retrospective treatment review on treatment strategies for pulmonary disease related to hematopoietic stem cell transplantation. [ Time Frame: Up to 15 years ]
    To review treatment strategies for pulmonary disease post transplant for effectiveness.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
A patient record captured during 01Jan2000 and 30Jun2011 from the medical record at The Ohio State University Medical Center who were seen post hematopoietic stem transplant.
Criteria

Inclusion Criteria:

  • Adult patients who have undergone a hematopoietic stem transplant (either at OSUMC or external location) and were seen at OSUMC at any time between 01Jan2000 and 30Jun2011.
  • Age > 18 years

Exclusion Criteria:

  • Age <18 years
  • Prisoners

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01420172


Locations
United States, Ohio
The Ohio State University Medical Center
Columbus, Ohio, United States, 43221
Sponsors and Collaborators
Karen Wood

Publications:
Responsible Party: Karen Wood, MD, Ohio State University
ClinicalTrials.gov Identifier: NCT01420172     History of Changes
Other Study ID Numbers: 2011H0214
First Posted: August 19, 2011    Key Record Dates
Last Update Posted: February 27, 2017
Last Verified: October 2015

Additional relevant MeSH terms:
Lung Diseases
Respiratory Tract Diseases